BRIEF-GSK announces positive results from two phase III studies of Incruse Ellipta
June 11, 2014 at 07:48 AM EDT
* GSK and Theravance announce positive data from two studies evaluating efficacy and safety of incruse ellipta when added to Relvar /Breo Ellipta in patients with COPD
